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The differential diagnosis of gingival hy-perplasia with or without hyperplasia of the palate mucosa includes inflammatory 
gingival hyperplasia, Dilantin hyperplasia, inflam-
matory papillary hyperplasia, and leukemia and 
lymphoma. Inflammatory hyperplasia of the gingiva 
usually results from prolonged chronic inflamma-
tion of gingival tissue, which could be associated 
with Vitamin C deficiency, endocrine imbalance, 
Crohn’s disease, or infection, including mucosal 
leishmaniasis. Gingival hyperplasia usually begins 
2 to 3 months after Dilantin therapy and is almost 
entirely confined to the gingival tissue surrounding 
the teeth. On rare occasions hyperplasia may occur 
in areas apart from the gingiva, such as the palate, 
in patients wearing a prosthetic appliance. Papillary 
Figure 1. Gingival hypertrophy with bleeding.
Figure 2. Cobblestone mucosa of the hard palate.
hyperplasia occurs predominately in edentulous pa-
tients with dentures.Gingival hyperplasia may be an 
early finding in patients with leukemia (e.g., AML) 
or lymphoma, secondary to infiltration of the gingi-
val mucosa.
A biopsy was performed from the oral mucosal 
lesion. Histological examination revealed pseudo-
epitheliomatous hyperplasia of the squamous epi-
thelium with dense inflammatory infiltrates in the 
dermis composed of lymphocytes, plasma cells and 
histiocytes containing numerous amastigote forms 
of Leishmania (Figure 3). Bone marrow aspiration 
and trephine examination showed no evidence 
of dissemination of leishmaniasis. A diagnosis of 
mucosal leishmaniasis was made and treatment was 
started with intramuscular meglumine antimoniate 
(20 mg/kg/day for 20 days). e patient showed a 
dramatic response and the oral lesions almost com-
pletely disappeared. 
Discussion
Leishmaniasis is infection by protozoans of the 
genus Leishmania. It is one of the neglected dis-
eases that usually afflict the world’s poorest people. 
Leishmaniasis is transmitted by the bite of sandfly 
and presents in three forms: cutaneous, mucocutane-
ous and visceral.1 Early descriptions of the parasite 
in cutaneous lesions were done by Cunningham, 
Borovsky and Wright between 1885 and 1903.2 
Other forms of leishmaniasis were described later. 
e clinical manifestation of leishmaniasis depends 
on the interaction between the characteristic viru-
lence of the species and host immune response.3 
Mucosal leishmaniasis is a chronic infection of 
the mucosal membranes, which in most cases is 
primary but may develop during or after an attack 
of visceral leishmaniasis. ere are at least 30 spe-
cies of Leishmania, of which 12 named and several 
un-named species affect man.4 Leishmania live two 
quite separate lives—one in the sandfly, the other 
in mammals. In the sandfly, the organism exists as 
the promastigote (Leptomonad), and in tissue as 
the amastigote (leishmanial or aflagellar form).5 
ese parasites are endemic to the tropics of the 
Americas, parts of Asia, Europe and tropical Africa 
north of the equator.1 ere are reports of mucosal 
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Figure 3. Histology of the oral lesion showing macrophages 
containing numerous Lieshman bodies (H&E stain, X400).
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leishmaniasis from different parts of the world, 
which almost in all cases involve the upper respira-
tory tract and/or oral mucosa.6-8
In Iran, infection by protozoa usually leads to 
visceral or cutaneous disease. Primary mucocutane-
ous or mucosal leishmaniasis is very rare. Our case is 
among the few reports of this condition from Iran. 
e clinical picture of this case appears to be more 
similar to the cases reported from Sudan.6 More 
cases need to be reported from Iran to be able to 
present the various characteristics, which may be 
unique to mucosal leishmaniasis in Iran.
